Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Comments of the Biotechnology Innovation…
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
Learn more
BIO Comments to FWS on Use of GMOs on National…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
Learn more
BIO Comments to the Minnesota Department of…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.    
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
Ted Roumel, Vice President for Research Innovation & Commercialization at the University of Maryland Biotechnology Institute, USA
March 10, 2016
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT for RESEARCH, INNOVATION AND COMMERCIALIZATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
BIO Testimony to the House Judiciary Committee Concerning the Hearing on Patent Reform
March 10, 2016
Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences Network (WABNet), Senegal
March 10, 2016
Government's role in developing solutions for diseases that disproportionately affect developing countries
Eileen Yen, former Director, Sarawak Biodiversity Centre, Malaysia
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH)
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA
The Patent Reform Act of 2007 - Coalition Letter
March 10, 2016
More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.
Animal Biotechnology: All About Animal Cloning
March 10, 2016
Cloning is the most recent evolution of selective assisted breeding in animal husbandry. Cloning animals is a reliable way of reproducing superior livestock genetics and ensuring herds are maintained at the highest quality possible.
BIO Statement: BIO Urges FDA Release of Risk Assessment on Animal Cloning
March 10, 2016
Letter to the dairy industry urging support for the U.S. Food and Drug Administration's release of the final risk assessment on animal cloning.
Agricultural Biotechnology is Helping Farmers Grow Food Sustainably
March 10, 2016
Biotechnology allows farmers to grow more food on less land using farming practices that are environmentally sustainable.
World Trade Organization: Comments on WTO Dispute Settlement Proceedings Regarding Biotech Products
March 10, 2016
BIO's comments on the World Trade Organization (WTO) Dispute Settlement Proceedings Regarding Measures of the European Communities Affecting the Approval and Marketing of Biotech Products to U.S. Trade Representative (USTR).